EUVIMED · CrossrefZeitschrift
Lung Cancer Management
ISSN 1758-1966 · Informa UK Limited
Neueste Artikel
Leveraging machine learning to predict de novo skin malignancy following lung transplantation
Cost of managing brain metastases in ALK-positive advanced NSCLC patients receiving first-line ALK TKIs in China
CyberKnife radical cure for early lung adenocarcinoma: a case was confirmed by postoperative pathology
At-home subcutaneous atezolizumab for non-small cell lung cancer: a prospective, single-arm phase II feasibility study
Potential to improve early detection of lung cancer through expansion of focused and opportunistic screening approaches: a scoping review focusing on potential expansion of screening risk factors and adoption of artificial intelligence models
Negative social determinants of health are linked to lung cancer screening underutilization
A Retrospective Study of Ensartinib-Treated ALK -Positive Locally Advanced or Metastatic NSCLC Patients in China
Enabling patients in effective self-management of breathlessness in lung cancer: the neglected pillar of personalized medicine
The Route to Diagnosis: Emergency Presentation of Lung Cancer
Nintedanib in Advanced NSCLC: Management of Adverse Events
Oncogenic ALK fusion in rare subtype of small intestine metastasis from occult lung cancer
Moving towards single fraction peripheral lung stereotactic body radiation therapy: patient care during and after the global COVID-19 pandemic
Cost of lung cancer diagnosis: cost differences between national health system and private sector
Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two cases
The association between blood-based HYAL2 methylation and early-stage lung cancer: a case-control study
Pooled analysis of oral vinorelbine as single agents in patients with advanced NSCLC
Lung cancer screening in limited resource regions: the 3rd Brazilian Early Lung Cancer Trial (BRELT3/mobile ProPulmão)
Construction and validation of an oxidative phosphorylation-related gene signature in lung squamous cell carcinoma patients
Community Hospital Experience Using Electromagnetic Navigation Bronchoscopy System Integrating Tidal Volume Computed Tomography Mapping
Clinical and Research Priorities for Combined Modality Therapy in Stage III NSCLC
Symptom Burden in Lung Cancer: Management Updates
Curative Intent Therapy in Oligometastatic Lung Cancer with an Unresectable Primary with N3 Nodes: Case Report and Review of the Literature
Neurotrophic Tyrosine Kinase Gene Fusions: Another Opportunity for Targeting in Lung Cancer
DNA Repair in Lung Cancer: Potential Not Yet Reached
Targeting EGFR and ALK in NSCLC: Current Evidence and Future Perspective
Liquid Biopsy and NSCLC
Recent Results of Immunotherapy and Perspectives for Advanced NSCLC
Lung Cancer Screening: Detected Nodules, What Next?
Lymph nodal Micrometastases in NSCLC: Where do we Stand?
Measurement of Quality of Life in Second-Line Patients with Advanced NSCLC without Targetable Mutations: A Review
EUVIMED